Starpharma Holdings is an Australian pharmaceutical company based in Melbourne that develops products built on dendrimer chemistry. Its main offering is VivaGel, a gel used to help prevent bacterial vaginosis and certain sexually transmitted infections, sold for women's health. The company also applies its dendrimer platform to drug delivery, working with partners to improve how medicines are formulated and released, and to agricultural and other specialty applications. Its customers are mainly healthcare consumers, medical partners and licensing collaborators.
Starpharma Holdings Ltd trades under the code SPL on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #735 of 1816 on the Australian Securities Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Australia yet.
TrendFair
58/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-26.5%
From 52-week high-46.6%
MomentumWeak
47/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-33.1%
6-month return-36.3%
12-month, skipping last month162.9%
Stability (higher is calmer)Fair
53/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)80.5%
Worst drawdown, 1 year (smaller is calmer)-46.6%
LiquidityStrong
83/100
Trades actively.
See the numbers →
Avg daily value traded1.97M AUD
Zero-volume days3.3%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Australia when fundamentals data for this market is added. All Australia stocks.
52-wk range 0.295 – 0.875Daily closes, split-adjusted
Signals
50-day average0.752
200-day average0.633
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.047
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 12 bearish
Weekly
Bearish
4 bullish · 1 neutral · 7 bearish
Monthly
Neutral
4 bullish · 1 neutral · 3 bearish
Moving averages (daily)
SMA 10
0.66
Bearish
EMA 10
0.62
Bearish
SMA 20
0.75
Bearish
EMA 20
0.69
Bearish
SMA 50
0.75
Bearish
EMA 50
0.73
Bearish
SMA 100
0.73
Bearish
EMA 100
0.72
Bearish
SMA 200
0.63
Bearish
EMA 200
0.63
Bearish
Oscillators (daily)
RSI (14)
17.37
Bullish
MACD (12, 26)
-0.07
Bearish
Momentum (12)
-43.98
Bearish
Stochastic %K (14)
7.06
Bullish
Williams %R (14)
-92.94
Bullish
CCI (20)
-198.5
Bullish
Pivot points (classic, last session)
S3
0.42
S2
0.43
S1
0.45
Pivot
0.46
R1
0.48
R2
0.49
R3
0.51
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in AUD. Educational only, not financial advice.
